{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T23:08:27Z","timestamp":1789168107903,"version":"build-2803163510"},"reference-count":111,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,6,17]],"date-time":"2023-06-17T00:00:00Z","timestamp":1686960000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,6,17]],"date-time":"2023-06-17T00:00:00Z","timestamp":1686960000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100019475","name":"Sidra Medical and Research Center","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100019475","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Transl Med"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>MicroRNAs (miRNAs) are small non-coding RNAs that play critical roles in regulating host gene expression. Recent studies have indicated a role of miRNAs in the pathogenesis of gestational diabetes mellitus (GDM), a common pregnancy-related disorder characterized by impaired glucose metabolism. Aberrant expression of miRNAs has been observed in the placenta and\/or maternal blood of GDM patients, suggesting their potential use as biomarkers for early diagnosis and prognosis. Additionally, several miRNAs have been shown to modulate key signaling pathways involved in glucose homeostasis, insulin sensitivity, and inflammation, providing insights into the pathophysiology of GDM. This review summarizes the current knowledge on the dynamics of miRNA in pregnancy, their role in GDM as well as their potential as diagnostic and therapeutic targets.<\/jats:p>","DOI":"10.1186\/s12967-023-04269-2","type":"journal-article","created":{"date-parts":[[2023,6,17]],"date-time":"2023-06-17T06:02:15Z","timestamp":1686981735000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":21,"title":["Exploring the potential of microRNA as a diagnostic tool for gestational diabetes"],"prefix":"10.1186","volume":"21","author":[{"given":"Duaa Ahmed","family":"Elhag","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4858-7130","authenticated-orcid":false,"given":"Souhaila","family":"Al Khodor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,6,17]]},"reference":[{"issue":"6","key":"4269_CR1","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1056\/NEJMoa012512","volume":"346","author":"WC Knowler","year":"2002","unstructured":"Knowler WC, et al. Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N Engl J Med. 2002;346(6):393\u2013403.","journal-title":"N Engl J Med"},{"issue":"2","key":"4269_CR2","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1007\/s00125-005-0097-z","volume":"49","author":"A Ramachandran","year":"2006","unstructured":"Ramachandran A, et al. The Indian diabetes prevention programme shows that lifestyle modification and metformin prevent type 2 diabetes in Asian Indian subjects with impaired glucose tolerance (IDPP-1). Diabetologia. 2006;49(2):289\u201397.","journal-title":"Diabetologia"},{"issue":"5","key":"4269_CR3","doi-asserted-by":"publisher","first-page":"323","DOI":"10.7326\/0003-4819-142-5-200503010-00007","volume":"142","author":"WH Herman","year":"2005","unstructured":"Herman WH, et al. The cost-effectiveness of lifestyle modification or metformin in preventing type 2 diabetes in adults with impaired glucose tolerance. Ann Intern Med. 2005;142(5):323\u201332.","journal-title":"Ann Intern Med"},{"issue":"18","key":"4269_CR4","doi-asserted-by":"publisher","first-page":"1343","DOI":"10.1056\/NEJM200105033441801","volume":"344","author":"J Tuomilehto","year":"2001","unstructured":"Tuomilehto J, et al. Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance. N Engl J Med. 2001;344(18):1343\u201350.","journal-title":"N Engl J Med"},{"issue":"10","key":"4269_CR5","doi-asserted-by":"publisher","first-page":"2026","DOI":"10.2337\/dc08-0972","volume":"31","author":"R Retnakaran","year":"2008","unstructured":"Retnakaran R, et al. Glucose intolerance in pregnancy and future risk of pre-diabetes or diabetes. Diabetes Care. 2008;31(10):2026\u201331.","journal-title":"Diabetes Care"},{"key":"4269_CR6","doi-asserted-by":"publisher","first-page":"109050","DOI":"10.1016\/j.diabres.2021.109050","volume":"183","author":"H Wang","year":"2022","unstructured":"Wang H, et al. IDF diabetes Atlas: estimation of global and regional gestational diabetes mellitus prevalence for 2021 by international association of diabetes in pregnancy study group\u2019s criteria. Diabetes Res Clin Pract. 2022;183:109050.","journal-title":"Diabetes Res Clin Pract"},{"issue":"7","key":"4269_CR7","doi-asserted-by":"publisher","first-page":"1151","DOI":"10.2337\/diacare.24.7.1151","volume":"24","author":"MI Schmidt","year":"2001","unstructured":"Schmidt MI, et al. Gestational diabetes mellitus diagnosed with a 2-h 75-g oral glucose tolerance test and adverse pregnancy outcomes. Diabetes Care. 2001;24(7):1151\u20135.","journal-title":"Diabetes Care"},{"issue":"7","key":"4269_CR8","doi-asserted-by":"publisher","first-page":"1713","DOI":"10.2337\/dc06-0635","volume":"29","author":"C Murgia","year":"2006","unstructured":"Murgia C, et al. Gestational diabetes mellitus in Sardinia: results from an early, universal screening procedure. Diabetes Care. 2006;29(7):1713\u20134.","journal-title":"Diabetes Care"},{"issue":"Suppl 1","key":"4269_CR9","doi-asserted-by":"publisher","first-page":"S15","DOI":"10.2337\/dc21-S002","volume":"44","author":"American Diabetes","year":"2021","unstructured":"American Diabetes. 2 Classification and diagnosis of diabetes: standards of medical care in diabetes-2021. Diabetes Care. 2021;44(Suppl 1):S15\u201333.","journal-title":"Diabetes Care"},{"issue":"2","key":"4269_CR10","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1159\/000324684","volume":"30","author":"W Plasencia","year":"2011","unstructured":"Plasencia W, et al. Criteria for screening and diagnosis of gestational diabetes mellitus in the first trimester of pregnancy. Fetal Diagn Ther. 2011;30(2):108\u201315.","journal-title":"Fetal Diagn Ther"},{"key":"4269_CR11","doi-asserted-by":"publisher","first-page":"611929","DOI":"10.3389\/fendo.2020.611929","volume":"11","author":"S Parrettini","year":"2020","unstructured":"Parrettini S, Caroli A, Torlone E. Nutrition and metabolic adaptations in physiological and complicated pregnancy: focus on obesity and gestational diabetes. Front Endocrinol (Lausanne). 2020;11:611929.","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"5","key":"4269_CR12","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1007\/s00101-018-0437-2","volume":"67","author":"LM Kohlhepp","year":"2018","unstructured":"Kohlhepp LM, et al. Physiological changes during pregnancy. Anaesthesist. 2018;67(5):383\u201396.","journal-title":"Anaesthesist"},{"issue":"1","key":"4269_CR13","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1186\/s12958-021-00883-1","volume":"20","author":"C Legare","year":"2022","unstructured":"Legare C, et al. Human plasma pregnancy-associated miRNAs and their temporal variation within the first trimester of pregnancy. Reprod Biol Endocrinol. 2022;20(1):14.","journal-title":"Reprod Biol Endocrinol"},{"key":"4269_CR14","doi-asserted-by":"publisher","first-page":"402","DOI":"10.3389\/fendo.2018.00402","volume":"9","author":"J O'Brien","year":"2018","unstructured":"O\u2019Brien J, et al. Overview of MicroRNA biogenesis, mechanisms of actions, and circulation. Front Endocrinol (Lausanne). 2018;9:402.","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"4 Suppl","key":"4269_CR15","doi-asserted-by":"publisher","first-page":"S173","DOI":"10.1016\/j.ajog.2015.07.001","volume":"213","author":"MD Mitchell","year":"2015","unstructured":"Mitchell MD, et al. Placental exosomes in normal and complicated pregnancy. Am J Obstet Gynecol. 2015;213(4 Suppl):S173\u201381.","journal-title":"Am J Obstet Gynecol"},{"issue":"5","key":"4269_CR16","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1007\/s11892-017-0856-5","volume":"17","author":"C Poirier","year":"2017","unstructured":"Poirier C, et al. MicroRNAs in pregnancy and gestational diabetes mellitus: emerging role in maternal metabolic regulation. Curr Diab Rep. 2017;17(5):35.","journal-title":"Curr Diab Rep"},{"key":"4269_CR17","doi-asserted-by":"publisher","first-page":"6972732","DOI":"10.1155\/2017\/6972732","volume":"2017","author":"M Cai","year":"2017","unstructured":"Cai M, Kolluru GK, Ahmed A. Small molecule, big prospects: MicroRNA in pregnancy and its complications. J Pregnancy. 2017;2017:6972732.","journal-title":"J Pregnancy"},{"issue":"6","key":"4269_CR18","doi-asserted-by":"publisher","first-page":"910","DOI":"10.1080\/01443615.2020.1820465","volume":"41","author":"U Akgor","year":"2021","unstructured":"Akgor U, Ayaz L, Cayan F. Expression levels of maternal plasma microRNAs in preeclamptic pregnancies. J Obstet Gynaecol. 2021;41(6):910\u20134.","journal-title":"J Obstet Gynaecol"},{"key":"4269_CR19","doi-asserted-by":"publisher","first-page":"1495082","DOI":"10.1155\/2022\/1495082","volume":"2022","author":"S Salimi","year":"2022","unstructured":"Salimi S, et al. Association of polymorphisms in miR146a, an inflammation-associated MicroRNA, with the risk of idiopathic recurrent spontaneous miscarriage: a case-control study. Dis Markers. 2022;2022:1495082.","journal-title":"Dis Markers"},{"issue":"8","key":"4269_CR20","doi-asserted-by":"publisher","first-page":"1088","DOI":"10.1038\/s41430-021-01041-x","volume":"76","author":"P Kochhar","year":"2022","unstructured":"Kochhar P, et al. microRNA signatures associated with fetal growth restriction: a systematic review. Eur J Clin Nutr. 2022;76(8):1088\u2013102.","journal-title":"Eur J Clin Nutr"},{"issue":"8","key":"4269_CR21","doi-asserted-by":"publisher","first-page":"e0236805","DOI":"10.1371\/journal.pone.0236805","volume":"15","author":"EE Winger","year":"2020","unstructured":"Winger EE, et al. MicroRNAs isolated from peripheral blood in the first trimester predict spontaneous preterm birth. PLoS ONE. 2020;15(8):e0236805.","journal-title":"PLoS ONE"},{"issue":"1","key":"4269_CR22","doi-asserted-by":"publisher","first-page":"3401","DOI":"10.1038\/s41598-018-21604-6","volume":"8","author":"L Yoffe","year":"2018","unstructured":"Yoffe L, et al. Early detection of preeclampsia using circulating small non-coding RNA. Sci Rep. 2018;8(1):3401.","journal-title":"Sci Rep"},{"issue":"5","key":"4269_CR23","doi-asserted-by":"publisher","first-page":"829","DOI":"10.1136\/gutjnl-2020-322065","volume":"70","author":"JBY So","year":"2021","unstructured":"So JBY, et al. Development and validation of a serum microRNA biomarker panel for detecting gastric cancer in a high-risk population. Gut. 2021;70(5):829\u201337.","journal-title":"Gut"},{"issue":"3","key":"4269_CR24","doi-asserted-by":"publisher","first-page":"472","DOI":"10.1038\/s41416-021-01593-6","volume":"126","author":"R Zou","year":"2022","unstructured":"Zou R, et al. Development and validation of a circulating microRNA panel for the early detection of breast cancer. Br J Cancer. 2022;126(3):472\u201381.","journal-title":"Br J Cancer"},{"key":"4269_CR25","doi-asserted-by":"publisher","DOI":"10.3390\/jcm11061632","author":"A Khan","year":"2022","unstructured":"Khan A, et al. Altered circulating microRNAs in patients with diabetic neuropathy and corneal nerve loss: a pilot study. J Clin Med. 2022. https:\/\/doi.org\/10.3390\/jcm11061632.","journal-title":"J Clin Med"},{"key":"4269_CR26","doi-asserted-by":"publisher","DOI":"10.3390\/ijms23084276","author":"T Filardi","year":"2022","unstructured":"Filardi T, et al. Identification and validation of miR-222\u20133p and miR-409\u20133p as plasma biomarkers in gestational diabetes mellitus sharing validated target genes involved in metabolic homeostasis. Int J Mol Sci. 2022. https:\/\/doi.org\/10.3390\/ijms23084276.","journal-title":"Int J Mol Sci"},{"issue":"2","key":"4269_CR27","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1016\/j.diabres.2003.07.004","volume":"62","author":"G Di Cianni","year":"2003","unstructured":"Di Cianni G, et al. Prevalence and risk factors for gestational diabetes assessed by universal screening. Diabetes Res Clin Pract. 2003;62(2):131\u20137.","journal-title":"Diabetes Res Clin Pract"},{"key":"4269_CR28","doi-asserted-by":"publisher","first-page":"E158","DOI":"10.5888\/pcd16.190212","volume":"16","author":"L Chen","year":"2019","unstructured":"Chen L, et al. Influence of acculturation on risk for gestational diabetes among Asian women. Prev Chronic Dis. 2019;16:E158.","journal-title":"Prev Chronic Dis"},{"issue":"3","key":"4269_CR29","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1016\/S0020-7292(01)00496-9","volume":"75","author":"X Xiong","year":"2001","unstructured":"Xiong X, et al. Gestational diabetes mellitus: prevalence, risk factors, maternal and infant outcomes. Int J Gynaecol Obstet. 2001;75(3):221\u20138.","journal-title":"Int J Gynaecol Obstet"},{"key":"4269_CR30","doi-asserted-by":"publisher","DOI":"10.3390\/ijms20133343","author":"A Martinez-Ibarra","year":"2019","unstructured":"Martinez-Ibarra A, et al. Unhealthy levels of phthalates and bisphenol a in Mexican pregnant women with gestational diabetes and its association to altered expression of miRNAs involved with metabolic disease. Int J Mol Sci. 2019. https:\/\/doi.org\/10.3390\/ijms20133343.","journal-title":"Int J Mol Sci"},{"issue":"6","key":"4269_CR31","doi-asserted-by":"publisher","first-page":"974","DOI":"10.1111\/jog.13317","volume":"43","author":"YL Cao","year":"2017","unstructured":"Cao YL, et al. Plasma microRNA-16-5p, -17-5p and -20a-5p: novel diagnostic biomarkers for gestational diabetes mellitus. J Obstet Gynaecol Res. 2017;43(6):974\u201381.","journal-title":"J Obstet Gynaecol Res"},{"key":"4269_CR32","doi-asserted-by":"publisher","first-page":"839344","DOI":"10.3389\/fendo.2022.839344","volume":"13","author":"I Juchnicka","year":"2022","unstructured":"Juchnicka I, et al. miRNAs as Predictive Factors in Early Diagnosis of Gestational Diabetes Mellitus. Front Endocrinol (Lausanne). 2022;13:839344.","journal-title":"Front Endocrinol (Lausanne)"},{"key":"4269_CR33","doi-asserted-by":"publisher","DOI":"10.3390\/biomedicines10020482","author":"AE Sorensen","year":"2022","unstructured":"Sorensen AE, et al. The temporal profile of circulating miRNAs during gestation in overweight and obese women with or without gestational diabetes mellitus. Biomedicines. 2022. https:\/\/doi.org\/10.3390\/biomedicines10020482.","journal-title":"Biomedicines"},{"issue":"1","key":"4269_CR34","doi-asserted-by":"publisher","first-page":"1366","DOI":"10.1038\/s41598-018-19200-9","volume":"8","author":"L Stirm","year":"2018","unstructured":"Stirm L, et al. Maternal whole blood cell miRNA-340 is elevated in gestational diabetes and inversely regulated by glucose and insulin. Sci Rep. 2018;8(1):1366.","journal-title":"Sci Rep"},{"key":"4269_CR35","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.diabres.2017.07.024","volume":"132","author":"PL Wander","year":"2017","unstructured":"Wander PL, et al. Circulating early- and mid-pregnancy microRNAs and risk of gestational diabetes. Diabetes Res Clin Pract. 2017;132:1\u20139.","journal-title":"Diabetes Res Clin Pract"},{"issue":"11","key":"4269_CR36","doi-asserted-by":"publisher","first-page":"5157","DOI":"10.1210\/jc.2018-02693","volume":"104","author":"V Gillet","year":"2019","unstructured":"Gillet V, et al. miRNA profiles in extracellular vesicles from serum early in pregnancies complicated by gestational diabetes mellitus. J Clin Endocrinol Metab. 2019;104(11):5157\u201369.","journal-title":"J Clin Endocrinol Metab"},{"key":"4269_CR37","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1016\/j.gene.2018.06.004","volume":"672","author":"A Tagoma","year":"2018","unstructured":"Tagoma A, et al. MicroRNA profiling of second trimester maternal plasma shows upregulation of miR-195-5p in patients with gestational diabetes. Gene. 2018;672:137\u201342.","journal-title":"Gene"},{"key":"4269_CR38","doi-asserted-by":"publisher","first-page":"345","DOI":"10.3389\/fendo.2017.00345","volume":"8","author":"G Sebastiani","year":"2017","unstructured":"Sebastiani G, et al. Circulating microRNA (miRNA) expression profiling in plasma of patients with gestational diabetes mellitus reveals upregulation of miRNA miR-330-3p. Front Endocrinol (Lausanne). 2017;8:345.","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"1","key":"4269_CR39","doi-asserted-by":"publisher","first-page":"908","DOI":"10.1038\/s41598-020-57838-6","volume":"10","author":"S Pfeiffer","year":"2020","unstructured":"Pfeiffer S, et al. Circulating miR-330-3p in late pregnancy is associated with pregnancy outcomes among lean women with GDM. Sci Rep. 2020;10(1):908.","journal-title":"Sci Rep"},{"issue":"3","key":"4269_CR40","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1007\/s40291-018-0325-0","volume":"22","author":"C Pheiffer","year":"2018","unstructured":"Pheiffer C, et al. Decreased expression of circulating miR-20a-5p in South African women with gestational diabetes mellitus. Mol Diagn Ther. 2018;22(3):345\u201352.","journal-title":"Mol Diagn Ther"},{"issue":"1","key":"4269_CR41","doi-asserted-by":"publisher","first-page":"57","DOI":"10.2174\/2211536611666220413100636","volume":"11","author":"R Bhushan","year":"2022","unstructured":"Bhushan R, et al. MicroRNA-7 regulates insulin signaling pathway by targeting IRS1, IRS2, and RAF1 genes in gestational diabetes mellitus. Microrna. 2022;11(1):57\u201372.","journal-title":"Microrna"},{"issue":"6","key":"4269_CR42","doi-asserted-by":"publisher","first-page":"825","DOI":"10.1515\/tjb-2019-0157","volume":"45","author":"S Balci","year":"2020","unstructured":"Balci S, et al. Expression level of miRNAS in patients with gestational diabetes. Turkish J Biochem. 2020;45(6):825\u201331.","journal-title":"Turkish J Biochem"},{"issue":"34","key":"4269_CR43","doi-asserted-by":"publisher","first-page":"e11891","DOI":"10.1097\/MD.0000000000011891","volume":"97","author":"X Zhang","year":"2018","unstructured":"Zhang X, et al. Association of gestational diabetes mellitus and abnormal vaginal flora with adverse pregnancy outcomes. Medicine (Baltimore). 2018;97(34):e11891.","journal-title":"Medicine (Baltimore)"},{"issue":"1","key":"4269_CR44","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1007\/s00592-010-0226-0","volume":"48","author":"L Kong","year":"2011","unstructured":"Kong L, et al. Significance of serum microRNAs in pre-diabetes and newly diagnosed type 2 diabetes: a clinical study. Acta Diabetol. 2011;48(1):61\u20139.","journal-title":"Acta Diabetol"},{"issue":"11","key":"4269_CR45","doi-asserted-by":"publisher","first-page":"406","DOI":"10.1007\/s13205-019-1952-9","volume":"9","author":"F Wang","year":"2019","unstructured":"Wang F, Zhang X, Zhou H. Role of cell free microRNA-19a and microRNA-19b in gestational diabetes mellitus patients. 3 Biotech. 2019;9(11):406.","journal-title":"3 Biotech"},{"issue":"1","key":"4269_CR46","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1016\/j.ijgo.2015.01.010","volume":"130","author":"Y Zhu","year":"2015","unstructured":"Zhu Y, et al. Profiling maternal plasma microRNA expression in early pregnancy to predict gestational diabetes mellitus. Int J Gynaecol Obstet. 2015;130(1):49\u201353.","journal-title":"Int J Gynaecol Obstet"},{"issue":"5","key":"4269_CR47","doi-asserted-by":"publisher","first-page":"e97632","DOI":"10.1371\/journal.pone.0097632","volume":"9","author":"LO Perucci","year":"2014","unstructured":"Perucci LO, et al. Soluble endoglin, transforming growth factor-Beta 1 and soluble tumor necrosis factor alpha receptors in different clinical manifestations of preeclampsia. PLoS ONE. 2014;9(5):e97632.","journal-title":"PLoS ONE"},{"issue":"6","key":"4269_CR48","doi-asserted-by":"publisher","first-page":"1397","DOI":"10.2337\/db09-1061","volume":"59","author":"A Kumar","year":"2010","unstructured":"Kumar A, et al. Fat cell-specific ablation of rictor in mice impairs insulin-regulated fat cell and whole-body glucose and lipid metabolism. Diabetes. 2010;59(6):1397\u2013406.","journal-title":"Diabetes"},{"issue":"5","key":"4269_CR49","doi-asserted-by":"publisher","first-page":"404","DOI":"10.5603\/EP.a2020.0046","volume":"71","author":"X Gao","year":"2020","unstructured":"Gao X, Zhao S. miRNA-16-5p inhibits the apoptosis of high glucose-induced pancreatic beta cells via targeting of CXCL10: potential biomarkers in type 1 diabetes mellitus. Endokrynol Pol. 2020;71(5):404\u201310.","journal-title":"Endokrynol Pol"},{"key":"4269_CR50","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1186\/s12974-015-0265-0","volume":"12","author":"EA Ye","year":"2015","unstructured":"Ye EA, Steinle JJ. miR-15b\/16 protects primary human retinal microvascular endothelial cells against hyperglycemia-induced increases in tumor necrosis factor alpha and suppressor of cytokine signaling 3. J Neuroinflammation. 2015;12:44.","journal-title":"J Neuroinflammation"},{"issue":"18","key":"4269_CR51","doi-asserted-by":"publisher","first-page":"3370","DOI":"10.1111\/j.1742-4658.2011.08261.x","volume":"278","author":"RM Carew","year":"2011","unstructured":"Carew RM, et al. Insulin receptor substrate 2 and FoxO3a signalling are involved in E-cadherin expression and transforming growth factor-beta1-induced repression in kidney epithelial cells. FEBS J. 2011;278(18):3370\u201380.","journal-title":"FEBS J"},{"issue":"16","key":"4269_CR52","doi-asserted-by":"publisher","first-page":"11230","DOI":"10.1074\/jbc.M113.544999","volume":"289","author":"Y Geng","year":"2014","unstructured":"Geng Y, et al. Insulin receptor substrate 1\/2 (IRS1\/2) regulates Wnt\/beta-catenin signaling through blocking autophagic degradation of dishevelled2. J Biol Chem. 2014;289(16):11230\u201341.","journal-title":"J Biol Chem"},{"issue":"1","key":"4269_CR53","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1002\/oby.21709","volume":"25","author":"MJ Hubal","year":"2017","unstructured":"Hubal MJ, et al. Circulating adipocyte-derived exosomal MicroRNAs associated with decreased insulin resistance after gastric bypass. Obesity (Silver Spring). 2017;25(1):102\u201310.","journal-title":"Obesity (Silver Spring)"},{"key":"4269_CR54","doi-asserted-by":"publisher","first-page":"6380463","DOI":"10.1155\/2018\/6380463","volume":"2018","author":"E Guarino","year":"2018","unstructured":"Guarino E, et al. Circulating MicroRNAs as biomarkers of gestational diabetes mellitus: updates and perspectives. Int J Endocrinol. 2018;2018:6380463.","journal-title":"Int J Endocrinol"},{"issue":"1","key":"4269_CR55","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1186\/s12933-022-01517-5","volume":"21","author":"C Eyileten","year":"2022","unstructured":"Eyileten C, et al. Alteration of circulating platelet-related and diabetes-related microRNAs in individuals with type 2 diabetes mellitus: a stepwise hypoglycaemic clamp study. Cardiovasc Diabetol. 2022;21(1):79.","journal-title":"Cardiovasc Diabetol"},{"issue":"4","key":"4269_CR56","doi-asserted-by":"publisher","first-page":"967","DOI":"10.3892\/ijmm.2016.2497","volume":"37","author":"X Liang","year":"2016","unstructured":"Liang X, et al. MicroRNA-16 suppresses the activation of inflammatory macrophages in atherosclerosis by targeting PDCD4. Int J Mol Med. 2016;37(4):967\u201375.","journal-title":"Int J Mol Med"},{"key":"4269_CR57","doi-asserted-by":"publisher","first-page":"108664","DOI":"10.1016\/j.biopha.2019.108664","volume":"112","author":"Y Yang","year":"2019","unstructured":"Yang Y, et al. miR-16 inhibits NLRP3 inflammasome activation by directly targeting TLR4 in acute lung injury. Biomed Pharmacother. 2019;112:108664.","journal-title":"Biomed Pharmacother"},{"issue":"6","key":"4269_CR58","doi-asserted-by":"publisher","first-page":"E1051","DOI":"10.1210\/jc.2011-3131","volume":"97","author":"W Wang","year":"2012","unstructured":"Wang W, et al. Preeclampsia up-regulates angiogenesis-associated microRNA (i.e., miR-17, -20a, and -20b) that target ephrin-B2 and EPHB4 in human placenta. J Clin Endocrinol Metab. 2012;97(6):E1051-9.","journal-title":"J Clin Endocrinol Metab"},{"issue":"22","key":"4269_CR59","doi-asserted-by":"publisher","first-page":"1481","DOI":"10.21037\/atm-20-6717","volume":"8","author":"L Li","year":"2020","unstructured":"Li L, et al. Correlation between alterations of gut microbiota and miR-122-5p expression in patients with type 2 diabetes mellitus. Ann Transl Med. 2020;8(22):1481.","journal-title":"Ann Transl Med"},{"key":"4269_CR60","doi-asserted-by":"publisher","first-page":"1031","DOI":"10.3389\/fmicb.2016.01031","volume":"7","author":"M Nuriel-Ohayon","year":"2016","unstructured":"Nuriel-Ohayon M, Neuman H, Koren O. Microbial changes during pregnancy, birth, and infancy. Front Microbiol. 2016;7:1031.","journal-title":"Front Microbiol"},{"issue":"3","key":"4269_CR61","doi-asserted-by":"publisher","first-page":"2604","DOI":"10.3892\/mmr.2017.6925","volume":"16","author":"M Wang","year":"2017","unstructured":"Wang M. miR-433 protects pancreatic beta cell growth in high-glucose conditions. Mol Med Rep. 2017;16(3):2604\u201310.","journal-title":"Mol Med Rep"},{"key":"4269_CR62","doi-asserted-by":"publisher","DOI":"10.3390\/biomedicines9081055","author":"R Badacz","year":"2021","unstructured":"Badacz R, et al. Expression of miR-1\u20133p, miR-16\u20135p and miR-122\u20135p as possible risk factors of secondary cardiovascular events. Biomedicines. 2021. https:\/\/doi.org\/10.3390\/biomedicines9081055.","journal-title":"Biomedicines"},{"issue":"11","key":"4269_CR63","doi-asserted-by":"publisher","first-page":"3851","DOI":"10.2337\/db13-0039","volume":"62","author":"MP Bhatt","year":"2013","unstructured":"Bhatt MP, et al. C-peptide activates AMPKalpha and prevents ROS-mediated mitochondrial fission and endothelial apoptosis in diabetes. Diabetes. 2013;62(11):3851\u201362.","journal-title":"Diabetes"},{"issue":"5","key":"4269_CR64","doi-asserted-by":"publisher","first-page":"1416","DOI":"10.1067\/mob.2002.127305","volume":"187","author":"JJ Brosens","year":"2002","unstructured":"Brosens JJ, Pijnenborg R, Brosens IA. The myometrial junctional zone spiral arteries in normal and abnormal pregnancies: a review of the literature. Am J Obstet Gynecol. 2002;187(5):1416\u201323.","journal-title":"Am J Obstet Gynecol"},{"key":"4269_CR65","doi-asserted-by":"publisher","DOI":"10.5114\/aoms\/145778","author":"J Li","year":"2022","unstructured":"Li J, et al. MicroRNA-17\u20135p acts as a biomarker and regulates mitochondrial dynamics in trophoblasts and endothelial cells by targeting the mitofusins Mfn1\/Mfn2 in gestational diabetes mellitus. Archiv Med Sci. 2022. https:\/\/doi.org\/10.5114\/aoms\/145778.","journal-title":"Archiv Med Sci"},{"issue":"2","key":"4269_CR66","doi-asserted-by":"publisher","first-page":"359","DOI":"10.5114\/aoms.2019.83291","volume":"15","author":"EA Dziedzic","year":"2019","unstructured":"Dziedzic EA, et al. Vitamin D level is associated with severity of coronary artery atherosclerosis and incidence of acute coronary syndromes in non-diabetic cardiac patients. Arch Med Sci. 2019;15(2):359\u201368.","journal-title":"Arch Med Sci"},{"key":"4269_CR67","doi-asserted-by":"publisher","DOI":"10.3390\/cells10010170","author":"AE Sorensen","year":"2021","unstructured":"Sorensen AE, et al. The predictive value of miR-16, -29a and -134 for early identification of gestational diabetes: a nested analysis of the DALI Cohort. Cells. 2021. https:\/\/doi.org\/10.3390\/cells10010170.","journal-title":"Cells"},{"issue":"1","key":"4269_CR68","doi-asserted-by":"publisher","first-page":"360","DOI":"10.1186\/s12967-021-02999-9","volume":"19","author":"S Nair","year":"2021","unstructured":"Nair S, et al. Extracellular vesicle-associated miRNAs are an adaptive response to gestational diabetes mellitus. J Transl Med. 2021;19(1):360.","journal-title":"J Transl Med"},{"issue":"Suppl 3","key":"4269_CR69","doi-asserted-by":"publisher","first-page":"S173","DOI":"10.1016\/S0020-7292(15)30033-3","volume":"131","author":"M Hod","year":"2015","unstructured":"Hod M, et al. The international federation of Gynecology and obstetrics (FIGO) initiative on gestational diabetes mellitus: a pragmatic guide for diagnosis, management, and care. Int J Gynaecol Obstet. 2015;131(Suppl 3):S173-211.","journal-title":"Int J Gynaecol Obstet"},{"key":"4269_CR70","doi-asserted-by":"publisher","first-page":"11420","DOI":"10.1038\/ncomms11420","volume":"7","author":"Y Chen","year":"2016","unstructured":"Chen Y, et al. Exosomal microRNA miR-92a concentration in serum reflects human brown fat activity. Nat Commun. 2016;7:11420.","journal-title":"Nat Commun"},{"issue":"12","key":"4269_CR71","doi-asserted-by":"publisher","first-page":"4089","DOI":"10.2337\/db14-0746","volume":"63","author":"M Chondronikola","year":"2014","unstructured":"Chondronikola M, et al. Brown adipose tissue improves whole-body glucose homeostasis and insulin sensitivity in humans. Diabetes. 2014;63(12):4089\u201399.","journal-title":"Diabetes"},{"key":"4269_CR72","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1016\/j.neures.2017.08.003","volume":"130","author":"M Lamadrid-Romero","year":"2018","unstructured":"Lamadrid-Romero M, et al. Central nervous system development-related microRNAs levels increase in the serum of gestational diabetic women during the first trimester of pregnancy. Neurosci Res. 2018;130:8\u201322.","journal-title":"Neurosci Res"},{"key":"4269_CR73","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1186\/1756-0500-6-491","volume":"6","author":"CV Collares","year":"2013","unstructured":"Collares CV, et al. Identifying common and specific microRNAs expressed in peripheral blood mononuclear cell of type 1, type 2, and gestational diabetes mellitus patients. BMC Res Notes. 2013;6:491.","journal-title":"BMC Res Notes"},{"issue":"5","key":"4269_CR74","first-page":"1529","volume":"12","author":"T Zhang","year":"2019","unstructured":"Zhang T, Ji C, Shi R. miR-142-3p promotes pancreatic beta cell survival through targeting FOXO1 in gestational diabetes mellitus. Int J Clin Exp Pathol. 2019;12(5):1529\u201338.","journal-title":"Int J Clin Exp Pathol"},{"issue":"10","key":"4269_CR75","doi-asserted-by":"publisher","first-page":"615","DOI":"10.1038\/nrendo.2013.157","volume":"9","author":"T Kitamura","year":"2013","unstructured":"Kitamura T. The role of FOXO1 in beta-cell failure and type 2 diabetes mellitus. Nat Rev Endocrinol. 2013;9(10):615\u201323.","journal-title":"Nat Rev Endocrinol"},{"issue":"10","key":"4269_CR76","doi-asserted-by":"publisher","first-page":"E1655","DOI":"10.1210\/jc.2013-1496","volume":"98","author":"A Prats-Puig","year":"2013","unstructured":"Prats-Puig A, et al. Changes in circulating microRNAs are associated with childhood obesity. J Clin Endocrinol Metab. 2013;98(10):E1655\u201360.","journal-title":"J Clin Endocrinol Metab"},{"issue":"5","key":"4269_CR77","doi-asserted-by":"publisher","first-page":"2231","DOI":"10.1016\/j.clnu.2018.09.024","volume":"38","author":"HA Al-Rawaf","year":"2019","unstructured":"Al-Rawaf HA. Circulating microRNAs and adipokines as markers of metabolic syndrome in adolescents with obesity. Clin Nutr. 2019;38(5):2231\u20138.","journal-title":"Clin Nutr"},{"issue":"5","key":"4269_CR78","doi-asserted-by":"publisher","first-page":"e0128372","DOI":"10.1371\/journal.pone.0128372","volume":"10","author":"P Prabu","year":"2015","unstructured":"Prabu P, et al. Circulating MiRNAs of \u201cAsian Indian Phenotype\u201d identified in subjects with impaired glucose tolerance and patients with type 2 diabetes. PLoS ONE. 2015;10(5):e0128372.","journal-title":"PLoS ONE"},{"key":"4269_CR79","doi-asserted-by":"publisher","first-page":"132","DOI":"10.3389\/fendo.2018.00132","volume":"9","author":"YZ Liang","year":"2018","unstructured":"Liang YZ, et al. Identification of neuroendocrine stress response-related circulating MicroRNAs as biomarkers for type 2 diabetes mellitus and insulin resistance. Front Endocrinol (Lausanne). 2018;9:132.","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"1","key":"4269_CR80","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1016\/j.cell.2011.08.033","volume":"147","author":"H Zhu","year":"2011","unstructured":"Zhu H, et al. The Lin28\/let-7 axis regulates glucose metabolism. Cell. 2011;147(1):81\u201394.","journal-title":"Cell"},{"issue":"11","key":"4269_CR81","doi-asserted-by":"publisher","first-page":"E1359","DOI":"10.1152\/ajpendo.00236.2013","volume":"305","author":"LQ Jiang","year":"2013","unstructured":"Jiang LQ, et al. Autocrine role of interleukin-13 on skeletal muscle glucose metabolism in type 2 diabetic patients involves microRNA let-7. Am J Physiol Endocrinol Metab. 2013;305(11):E1359\u201366.","journal-title":"Am J Physiol Endocrinol Metab"},{"issue":"8","key":"4269_CR82","doi-asserted-by":"publisher","first-page":"e23325","DOI":"10.1002\/jcla.23325","volume":"34","author":"J Wang","year":"2020","unstructured":"Wang J, et al. Serum miR-195-5p is upregulated in gestational diabetes mellitus. J Clin Lab Anal. 2020;34(8):e23325.","journal-title":"J Clin Lab Anal"},{"issue":"12","key":"4269_CR83","doi-asserted-by":"publisher","first-page":"E2271","DOI":"10.1210\/jc.2012-1996","volume":"97","author":"DS Karolina","year":"2012","unstructured":"Karolina DS, et al. Circulating miRNA profiles in patients with metabolic syndrome. J Clin Endocrinol Metab. 2012;97(12):E2271\u20136.","journal-title":"J Clin Endocrinol Metab"},{"issue":"22","key":"4269_CR84","doi-asserted-by":"publisher","first-page":"2451","DOI":"10.1042\/CS20180487","volume":"132","author":"S Nair","year":"2018","unstructured":"Nair S, et al. Human placental exosomes in gestational diabetes mellitus carry a specific set of miRNAs associated with skeletal muscle insulin sensitivity. Clin Sci (Lond). 2018;132(22):2451\u201367.","journal-title":"Clin Sci (Lond)"},{"issue":"2","key":"4269_CR85","doi-asserted-by":"publisher","first-page":"546","DOI":"10.3892\/ijmm.2020.4626","volume":"46","author":"AS Herrera-Van Oostdam","year":"2020","unstructured":"Herrera-Van Oostdam AS, et al. Placental exosomes isolated from urine of patients with gestational diabetes exhibit a differential profile expression of microRNAs across gestation. Int J Mol Med. 2020;46(2):546\u201360.","journal-title":"Int J Mol Med"},{"key":"4269_CR86","doi-asserted-by":"publisher","DOI":"10.3390\/ncrna4040032","author":"A Ibarra","year":"2018","unstructured":"Ibarra A, et al. Diabetes in pregnancy and MicroRNAs: promises and limitations in their clinical application. Noncodind RNA. 2018. https:\/\/doi.org\/10.3390\/ncrna4040032.","journal-title":"Noncodind RNA"},{"issue":"5","key":"4269_CR87","doi-asserted-by":"publisher","first-page":"1982","DOI":"10.1210\/en.2013-2046","volume":"155","author":"Z Shi","year":"2014","unstructured":"Shi Z, et al. Differential expression of microRNAs in omental adipose tissue from gestational diabetes mellitus subjects reveals miR-222 as a regulator of ERalpha expression in estrogen-induced insulin resistance. Endocrinology. 2014;155(5):1982\u201390.","journal-title":"Endocrinology"},{"issue":"1","key":"4269_CR88","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1080\/09674845.2020.1764211","volume":"78","author":"A Abdeltawab","year":"2021","unstructured":"Abdeltawab A, et al. Circulating micro RNA-223 and angiopoietin-like protein 8 as biomarkers of gestational diabetes mellitus. Br J Biomed Sci. 2021;78(1):12\u20137.","journal-title":"Br J Biomed Sci"},{"key":"4269_CR89","first-page":"896362","volume":"2012","author":"LB Nielsen","year":"2012","unstructured":"Nielsen LB, et al. Circulating levels of microRNA from children with newly diagnosed type 1 diabetes and healthy controls: evidence that miR-25 associates to residual beta-cell function and glycaemic control during disease progression. Exp Diabetes Res. 2012;2012:896362.","journal-title":"Exp Diabetes Res"},{"key":"4269_CR90","first-page":"1177","volume":"16","author":"K Xu","year":"2017","unstructured":"Xu K, et al. microRNA-503 contribute to pancreatic beta cell dysfunction by targeting the mTOR pathway in gestational diabetes mellitus. EXCLI J. 2017;16:1177\u201387.","journal-title":"EXCLI J"},{"issue":"1","key":"4269_CR91","first-page":"65","volume":"68","author":"J Wen","year":"2021","unstructured":"Wen J, Bai X. miR-520h Inhibits cell survival by targeting mTOR in gestational diabetes mellitus. Acta Biochim Pol. 2021;68(1):65\u201370.","journal-title":"Acta Biochim Pol"},{"issue":"5","key":"4269_CR92","doi-asserted-by":"publisher","first-page":"7141","DOI":"10.1002\/jcp.27468","volume":"234","author":"P Wang","year":"2019","unstructured":"Wang P, et al. Dysregulation of microRNA-657 influences inflammatory response via targeting interleukin-37 in gestational diabetes mellitus. J Cell Physiol. 2019;234(5):7141\u20138.","journal-title":"J Cell Physiol"},{"key":"4269_CR93","doi-asserted-by":"publisher","first-page":"4851214","DOI":"10.1155\/2019\/4851214","volume":"2019","author":"P Wang","year":"2019","unstructured":"Wang P, et al. miR-657 promotes macrophage polarization toward M1 by targeting FAM46C in gestational diabetes mellitus. Mediators Inflamm. 2019;2019:4851214.","journal-title":"Mediators Inflamm"},{"key":"4269_CR94","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1016\/j.mvr.2018.03.002","volume":"118","author":"HY Peng","year":"2018","unstructured":"Peng HY, Li HP, Li MQ. High glucose induces dysfunction of human umbilical vein endothelial cells by upregulating miR-137 in gestational diabetes mellitus. Microvasc Res. 2018;118:90\u2013100.","journal-title":"Microvasc Res"},{"issue":"1","key":"4269_CR95","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1159\/000430349","volume":"37","author":"J Li","year":"2015","unstructured":"Li J, et al. A MicroRNA signature in gestational diabetes mellitus associated with risk of macrosomia. Cell Physiol Biochem. 2015;37(1):243\u201352.","journal-title":"Cell Physiol Biochem"},{"issue":"3","key":"4269_CR96","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1080\/09513590.2020.1843620","volume":"37","author":"M Hocaoglu","year":"2021","unstructured":"Hocaoglu M, et al. Identification of miR-16-5p and miR-155-5p microRNAs differentially expressed in circulating leukocytes of pregnant women with polycystic ovary syndrome and gestational diabetes. Gynecol Endocrinol. 2021;37(3):216\u201320.","journal-title":"Gynecol Endocrinol"},{"issue":"8","key":"4269_CR97","doi-asserted-by":"publisher","first-page":"e23925","DOI":"10.1371\/journal.pone.0023925","volume":"6","author":"C Zhao","year":"2011","unstructured":"Zhao C, et al. Early second-trimester serum miRNA profiling predicts gestational diabetes mellitus. PLoS ONE. 2011;6(8):e23925.","journal-title":"PLoS ONE"},{"key":"4269_CR98","doi-asserted-by":"publisher","first-page":"169","DOI":"10.3389\/fendo.2020.00169","volume":"11","author":"DG Sun","year":"2020","unstructured":"Sun DG, et al. The miRNA-29b Is downregulated in placenta during gestational diabetes mellitus and may alter placenta development by regulating trophoblast migration and invasion through a HIF3A-dependent mechanism. Front Endocrinol (Lausanne). 2020;11:169.","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"8","key":"4269_CR99","doi-asserted-by":"publisher","first-page":"107959","DOI":"10.1016\/j.jdiacomp.2021.107959","volume":"35","author":"L Zhang","year":"2021","unstructured":"Zhang L, et al. Down-regulation of microRNA-30d-5p is associated with gestational diabetes mellitus by targeting RAB8A. J Diabetes Complicat. 2021;35(8):107959.","journal-title":"J Diabetes Complicat"},{"key":"4269_CR100","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1016\/j.preghy.2019.04.004","volume":"17","author":"M Hocaoglu","year":"2019","unstructured":"Hocaoglu M, et al. Differential expression of candidate circulating microRNAs in maternal blood leukocytes of the patients with preeclampsia and gestational diabetes mellitus. Pregnancy Hypertens. 2019;17:5\u201311.","journal-title":"Pregnancy Hypertens"},{"key":"4269_CR101","first-page":"1297","volume":"16","author":"Y He","year":"2017","unstructured":"He Y, et al. miR-494 protects pancreatic beta-cell function by targeting PTEN in gestational diabetes mellitus. EXCLI J. 2017;16:1297\u2013307.","journal-title":"EXCLI J"},{"issue":"4","key":"4269_CR102","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1007\/s40291-019-00404-2","volume":"23","author":"C Pheiffer","year":"2019","unstructured":"Pheiffer C, et al. MicroRNA profiling in HIV-infected South African women with gestational diabetes mellitus. Mol Diagn Ther. 2019;23(4):499\u2013505.","journal-title":"Mol Diagn Ther"},{"issue":"12","key":"4269_CR103","doi-asserted-by":"publisher","first-page":"100406","DOI":"10.1016\/j.cpcardiol.2018.12.003","volume":"45","author":"MC Florio","year":"2020","unstructured":"Florio MC, et al. Aging, MicroRNAs, and heart failure. Curr Probl Cardiol. 2020;45(12):100406.","journal-title":"Curr Probl Cardiol"},{"issue":"5","key":"4269_CR104","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1038\/ng1536","volume":"37","author":"A Krek","year":"2005","unstructured":"Krek A, et al. Combinatorial microRNA target predictions. Nat Genet. 2005;37(5):495\u2013500.","journal-title":"Nat Genet"},{"issue":"14","key":"4269_CR105","doi-asserted-by":"publisher","first-page":"3955","DOI":"10.1158\/1078-0432.CCR-12-3302","volume":"19","author":"LC Bovell","year":"2013","unstructured":"Bovell LC, et al. The prognostic value of microRNAs varies with patient race\/ethnicity and stage of colorectal cancer. Clin Cancer Res. 2013;19(14):3955\u201365.","journal-title":"Clin Cancer Res"},{"key":"4269_CR106","doi-asserted-by":"publisher","first-page":"138\u2013143 e5","DOI":"10.1016\/j.jpeds.2021.03.070","volume":"235","author":"GM Karere","year":"2021","unstructured":"Karere GM, et al. Sex Differences in MicroRNA expression and cardiometabolic risk factors in hispanic adolescents with obesity. J Pediatr. 2021;235:138-143 e5.","journal-title":"J Pediatr"},{"issue":"5","key":"4269_CR107","doi-asserted-by":"publisher","first-page":"358","DOI":"10.1038\/nrg3198","volume":"13","author":"CC Pritchard","year":"2012","unstructured":"Pritchard CC, Cheng HH, Tewari M. MicroRNA profiling: approaches and considerations. Nat Rev Genet. 2012;13(5):358\u201369.","journal-title":"Nat Rev Genet"},{"issue":"7","key":"4269_CR108","doi-asserted-by":"publisher","first-page":"e41561","DOI":"10.1371\/journal.pone.0041561","volume":"7","author":"K Wang","year":"2012","unstructured":"Wang K, et al. Comparing the MicroRNA spectrum between serum and plasma. PLoS ONE. 2012;7(7):e41561.","journal-title":"PLoS ONE"},{"key":"4269_CR109","doi-asserted-by":"publisher","first-page":"1080157","DOI":"10.1155\/2017\/1080157","volume":"2017","author":"S Dias","year":"2017","unstructured":"Dias S, et al. MicroRNA expression varies according to glucose tolerance, measurement platform, and biological source. Biomed Res Int. 2017;2017:1080157.","journal-title":"Biomed Res Int"},{"issue":"1","key":"4269_CR110","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/j.cell.2004.12.035","volume":"120","author":"BP Lewis","year":"2005","unstructured":"Lewis BP, Burge CB, Bartel DP. Conserved seed pairing, often flanked by adenosines, indicates that thousands of human genes are microRNA targets. Cell. 2005;120(1):15\u201320.","journal-title":"Cell"},{"issue":"21","key":"4269_CR111","doi-asserted-by":"publisher","first-page":"e25808","DOI":"10.1097\/MD.0000000000025808","volume":"100","author":"X Yu","year":"2021","unstructured":"Yu X, et al. miR-96-5p: A potential diagnostic marker for gestational diabetes mellitus. Medicine (Baltimore). 2021;100(21):e25808.","journal-title":"Medicine (Baltimore)"}],"container-title":["Journal of Translational Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12967-023-04269-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12967-023-04269-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12967-023-04269-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,6,17]],"date-time":"2023-06-17T07:03:30Z","timestamp":1686985410000},"score":1,"resource":{"primary":{"URL":"https:\/\/translational-medicine.biomedcentral.com\/articles\/10.1186\/s12967-023-04269-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,6,17]]},"references-count":111,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["4269"],"URL":"https:\/\/doi.org\/10.1186\/s12967-023-04269-2","relation":{},"ISSN":["1479-5876"],"issn-type":[{"value":"1479-5876","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,6,17]]},"assertion":[{"value":"26 April 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 June 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 June 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"All authors reviewed the final version of the manuscript and approved it for publication.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"392"}}